Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_provenance.
- NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_assertion description "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_provenance.
- NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_assertion evidence source_evidence_literature NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_provenance.
- NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_assertion SIO_000772 9746492 NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_provenance.
- NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_assertion wasDerivedFrom befree-20140225 NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_provenance.
- NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_assertion wasGeneratedBy ECO_0000203 NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_provenance.